High therapeutic potential for systemic delivery of a liposome-conjugated herpes simplex virus.
Shikano T, Kasuya H, Sahin TT, Nomura N, Kanzaki A, Misawa M, Nishikawa Y, Shirota T, Yamada S, Fujii T, Sugimoto H, Kanazumi N, Nomoto S, Takeda S, Nakao A.
Shikano T, et al. Among authors: nomoto s.
Curr Cancer Drug Targets. 2011 Jan;11(1):111-22. doi: 10.2174/156800911793743673.
Curr Cancer Drug Targets. 2011.
PMID: 21062239
Review.